Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Bausch & Lomb acquires loteprednol etabonate line

Oct. 15, 2001

Asahi Glass describes novel antiglaucoma difluoroprostaglandins

Oct. 11, 2001

Indian research institute evaluates andrographolide derivatives

Sep. 21, 2001

Enrollment of patients completed for phase III INS-365 Ophthalmic clinical program

Sep. 19, 2001

Further submissions announced for Visudyne

Sep. 13, 2001

Novartis, QLT seek approval for expanded use of Visudyne in E.U.

Sep. 12, 2001

Senju to develop ocular formulation of betotastine

Sep. 4, 2001

Alcon presents potential antiglaucoma 13-oxaprostaglandins at the ACS meeting

Aug. 31, 2001

Sumitomo claims compounds useful for neuroretinal degenerative diseases

Aug. 31, 2001

Medennium's SmartPlug receives E.U. clearance for treatment of dry eyes

Aug. 29, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...